أرسل هذا في رسالة قصيرة: Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials

 _____      _____    __   _    _    _     _____   
|  __ \\   |  ___|| | || | || | || | ||  /  ___|| 
| |  \ ||  | ||__   | '--' || | || | || | // __   
| |__/ ||  | ||__   | .--. || | \\_/ || | \\_\ || 
|_____//   |_____|| |_|| |_||  \____//   \____//  
 -----`    `-----`  `-`  `-`    `---`     `---`